Milestone Pharmaceuticals Inc [NASDAQ: MIST] stock went on an upward path that rose over 16.00% on Monday, amounting to a one-week price increase of more than 25.41%.
Over the last 12 months, MIST stock dropped by -1.69%. The one-year Milestone Pharmaceuticals Inc stock forecast points to a potential upside of 38.13. The average equity rating for MIST stock is currently 1.80, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $197.59 million, with 85.17 million shares outstanding and 84.24 million shares in the current float. Compared to the average trading volume of 1.35M shares, MIST stock reached a trading volume of 9375691 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Milestone Pharmaceuticals Inc [MIST]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MIST shares is $3.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MIST stock is a recommendation set at 1.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wells Fargo have made an estimate for Milestone Pharmaceuticals Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on September 11, 2025. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on June 05, 2025, representing the official price target for Milestone Pharmaceuticals Inc stock. Previously, the target price had yet another raise to $9, while Rodman & Renshaw analysts kept a Buy rating on MIST stock. On June 20, 2023, analysts decreased their price target for MIST shares from 8 to 4.
The Price to Book ratio for the last quarter was 9.64, with the Price to Cash per share for the same quarter was set at 0.97.
MIST Stock Performance Analysis:
Milestone Pharmaceuticals Inc [MIST] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 25.41. With this latest performance, MIST shares gained by 19.59% in over the last four-week period, additionally plugging by 79.84% over the last 6 months – not to mention a drop of -1.69% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MIST stock in for the last two-week period is set at 71.29, with the RSI for the last a single of trading hit 0.16, and the three-weeks RSI is set at 0.13 for Milestone Pharmaceuticals Inc [MIST]. The present Moving Average for the last 50 days of trading for this stock 1.95, while it was recorded at 2.01 for the last single week of trading, and 1.70 for the last 200 days.
Milestone Pharmaceuticals Inc (MIST) Capital Structure & Debt Analysis
According to recent financial data for Milestone Pharmaceuticals Inc. ( MIST), the Return on Equity (ROE) stands at -260.65%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -68.07%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Milestone Pharmaceuticals Inc’s Return on Invested Capital (ROIC) is -75.12%, showcasing its effectiveness in deploying capital for earnings.
Milestone Pharmaceuticals Inc (MIST) Efficiency & Liquidity Metrics
Based on Milestone Pharmaceuticals Inc’s (MIST) latest financial statements, the Debt-to-Equity Ratio is 2.79%, indicating its reliance on debt financing relative to shareholder equity.
Milestone Pharmaceuticals Inc (MIST) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Milestone Pharmaceuticals Inc. (MIST) effectively leverages its workforce, generating an average of -$1757878.79 per employee. The company’s liquidity position is robust, with a Current Ratio of 8.24% and a Quick Ratio of 8.24%, indicating strong ability to cover short-term liabilities.
MIST Stock EPS
With the latest financial reports released by the company, Milestone Pharmaceuticals Inc posted -0.19/share EPS, while the average EPS was predicted by analysts to be reported at -0.15/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.04. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MIST. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Milestone Pharmaceuticals Inc go to -10.85%.
Milestone Pharmaceuticals Inc [MIST] Institutonal Ownership Details
There are presently around $46.26%, or 47.87%% of MIST stock, in the hands of institutional investors. The top three institutional holders of MIST stocks are: BLACKROCK INC. with ownership of 4.97 million shares, which is approximately 7.5135%. RTW INVESTMENTS, LP, holding 3.26 million shares of the stock with an approximate value of $$4.3 million in MIST stocks shares; and RTW INVESTMENTS, LP, currently with $$3.66 million in MIST stock with ownership which is approximately 4.1561%.
